We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$362M
Cap. Flow
-$348M
Cap. Flow %
-25.31%
Top 10 Hldgs %
62.01%
Holding
142
New
43
Increased
15
Reduced
9
Closed
60

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$53.1M
2
KSU
Kansas City Southern
KSU
+$31.9M
3
PF
Pinnacle Foods, Inc.
PF
+$27.7M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$5.3M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.43M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12.3M
2
INSM icon
Insmed
INSM
+$7.51M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$6.36M
4
DYNC
Vistra Energy Corp.
DYNC
+$5.07M
5
NXH
Neighborhood Intelligence Inc
NXH
+$3.25M

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.94%
2 Technology 3.93%
3 Industrials 2.49%
4 Consumer Staples 2.13%
5 Healthcare 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
76
CALL
Insmed
INSM
$25.9B
– –
-213,000
Closed -$6.64M
INSM icon
77
Insmed
INSM
$25.9B
– –
-240,600
Closed -$7.51M
INSM icon
78
PUT
Insmed
INSM
$25.9B
– –
-376,700
Closed -$11.8M
MNOV icon
79
PUT
MediciNova
MNOV
$70.9M
– –
-43,800
Closed -$279K
NBIX icon
80
Neurocrine Biosciences
NBIX
$15.7B
– –
-103,800
Closed -$6.36M
NBR icon
81
Nabors Industries
NBR
$1.39B
– –
-3,178
Closed -$1.01M
NBR icon
82
PUT
Nabors Industries
NBR
$1.39B
– –
-2,000
Closed -$807K
PTCT icon
83
PTC Therapeutics
PTCT
$5.85B
– –
-612,543
Closed -$12.3M
PTCT icon
84
PUT
PTC Therapeutics
PTCT
$5.85B
– –
-1,735,300
Closed -$34.7M
RWM icon
85
ProShares Short Russell2000
RWM
$104M
– –
-6,000
Closed -$262K
T icon
86
PUT
AT&T
T
$178B
– –
-13,240
Closed -$391K
TEVA icon
87
Teva Pharmaceuticals
TEVA
$42.5B
– –
-83,900
Closed -$1.26M
TEVA icon
88
PUT
Teva Pharmaceuticals
TEVA
$42.5B
– –
-142,300
Closed -$2.5M
ARAV
89
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-94,550
Closed -$1.37M
SIOX
90
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-184,400
Closed -$10.1M
DISCK
91
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
– –
-11,000
Closed -$223K
AKRX
92
DELISTED
Akorn Inc
AKRX
– –
-10,000
Closed -$332K
CYOU
93
DELISTED
Changyou.com Limited American Depositary Share
CYOU
– –
-7,278
Closed -$288K
DYNC
94
DELISTED
Vistra Energy Corp.
DYNC
– –
-75,000
Closed -$5.07M
SPA
95
DELISTED
Sparton
SPA
– –
-16,554
Closed -$384K
OA
96
DELISTED
Orbital ATK, Inc.
OA
– –
-2,000
Closed -$266K
YUME
97
DELISTED
YuMe, Inc.
YUME
– –
-10,000
Closed -$46K
GLBL
98
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
– –
-20,795
Closed -$99K
RT
99
DELISTED
Ruby Tuesday Georgia
RT
– –
-10,000
Closed -$21K
CBF
100
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
– –
-14,000
Closed -$575K
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return

DLD Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, DLD Asset Management held 142 positions worth $1.38B, up 36% from $1.02B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

DLD Asset Management withdrew a net $348M in Q4 2017, closing 60 positions and reducing 9 holdings. Its most notable exit was PTC Therapeutics, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.

Against the trend, DLD Asset Management opened a new position in Cognizant worth $51.6M.

  • DLD Asset Management's largest Q4 2017 buy was Cognizant: 726,740 shares worth $51.6M.
  • DLD Asset Management added most to Otonomy, Inc. in Q4 2017, an estimated $1.16M increase.
  • DLD Asset Management's biggest Q4 2017 reduction was Lipocine, cutting an estimated $1.03M.
  • DLD Asset Management fully exited PTC Therapeutics in Q4 2017, selling an estimated $12.3M.
  • DLD Asset Management's ten largest holdings make up 62% of its $1.38B portfolio in Q4 2017.
  • DLD Asset Management opened 43 new positions and closed 60 in Q4 2017.
  • DLD Asset Management's portfolio value rose 36% quarter-over-quarter to $1.38B.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.